STEVEN H. ROUHANDEH - Corporate Board Profile

ABEONA THERAPEUTICS INC.

Filing Date	Source Excerpt
2008-04-22	Steven H. Rouhandeh became a director and Chairman of the Board on March 4, 2008.
2009-04-22	Mr. Steven H. Rouhandeh became a director and Chairman of the Board on March 4, 2008. ... Mr. Rouhandeh does not have any options or warrants outstanding at December 31, 2008.
2010-04-16	Steven H. Rouhandeh is Chairman of the Board*; Mr. Rouhandeh does not have any options or warrants outstanding at December 31, 2009.
2011-04-14	Steven H. Rouhandeh, 54, Chairman of the Board*
2012-04-16	Steven H. Rouhandeh became a director and Chairman of the Board on March 4, 2008. He is aChief Investment Officer of SCO Capital Partners, a group of New York based life sciences funds. Mr. Rouhandeh does not have any options or warrants outstanding at December 31, 2011.
2013-04-02	Steven H. Rouhandeh became a director and Chairman of the Board on March 4, 2008. He is aChief Investment Officer of SCO Capital Partners, a group of New York based life sciences funds. He possesses a diverse background in financial services that includes experience in asset management, corporate finance, investment banking and law. He has been active throughout recent years as an executive in venture capital and as a founder of several companies in the biotech field. His experience also includes positions as Managing Director of a private equity group at Metzler Bank, a private European investment firm and Vice President, Investment Banking at Deutsche Morgan Grenfell. Mr. Rouhandeh was also a corporate attorney at New York City-based Cravath, Swaine & Moore. Mr. Rouhandeh holds a J.D., from Harvard Law School, Harvard University and B.A. Government, Economics, from Southern Illinois University. Mr. Rouhandeh’s qualifications to serve our Board include his institutional knowledge of our Company and his extensive domestic and international financial experience in the healthcare industry. In addition, his expertise as founder and Chief Investment Officer of SCO Capital Partners, L.P. is important to the Company in all areas of operation and development including corporate finance, investment banking and business strategy.
2014-04-15	Steven H. Rouhandeh 57 Chairman of the Board*
2015-04-07	Steven H. Rouhandeh 58 Chairman of the Board and Executive Chairman* ... During 2014, Mr. Rouhandeh received 80,000 shares of Common Stock for their compensation as directors. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2014: Steven H. Rouhandeh 523,000 ... Mr. Rouhandeh, our Chairman of the Board, became Executive Chairman on January 1, 2015, the principal executive officer of the Company. ... Mr. Rouhandeh has been a director and Chairman of the Board since March 4, 2008.
2016-04-06	Steven H. Rouhandeh Executive Chairman
2017-04-11	Steven H. Rouhandeh, 60, became our Executive Chairman, Principal Executive Officer, on January 1, 2015. Mr. Rouhandeh has been a director and Chairman of the Board since March 4, 2008. ... Mr. Rouhandeh, our Chairman of the Board, became Executive Chairman on January 1, 2015, the principal executive officer of the Company. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2016: ... Steven H. Rouhandeh Executive Chairman ... Total ($) 1,656,000 ... Summary Compensation Table ... Steven H. Rouhandeh Executive Chairman 2016 ... Total ($) 1,656,000
2018-04-10	Steven H. Rouhandeh 61 Chairman of the Board and Executive Chairman*
2019-04-11	Steven H. Rouhandeh, 62, became our Executive Chairman (principal executive officer), on January 1, 2015. Mr. Rouhandeh has been a director and Chairman of the Board since March 4, 2008.
2020-04-10	Steven H. Rouhandeh, 63, Chairman of the Board and Executive Chairman
2021-04-09	Steven H. Rouhandeh, 64, has been Chairman of the Board since September 30, 2020 and was our Executive Chairman (principal executive officer) from January 1, 2015 until April 15, 2020. Mr. Rouhandeh has been a director since March 4, 2008.